A Prospective, Randomized, Double-Blind, Placebo Controlled Study of the Long-Term Efficacy of Nebivolol in Hypertensive Patients After Withdrawal of Therapy.

Trial Profile

A Prospective, Randomized, Double-Blind, Placebo Controlled Study of the Long-Term Efficacy of Nebivolol in Hypertensive Patients After Withdrawal of Therapy.

Completed
Phase of Trial: Phase IV

Latest Information Update: 19 Aug 2010

At a glance

  • Drugs Nebivolol (Primary)
  • Indications Hypertension
  • Focus Pharmacodynamics
  • Sponsors Forest Laboratories
  • Most Recent Events

    • 07 May 2010 Results presented at the 25th Annual Scientific Meeting of the American Society of Hypertension.
    • 14 Apr 2010 Actual patient number (207) added as reported by ClinicalTrials.gov.
    • 07 Oct 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top